Abstract
A 21-year-old woman with severe aplastic anemia received an allogeneic bone marrow transplant (allo-BMT) from an HLA-matched and ABO-matched sibling donor after conditioning with cyclophosphamide, rabbit ATG (Lymphoglobuline; Aventis-Pharma), and total lymphoid irradiation. She had a long history of cyclosporin A (CsA) therapy before conditioning. She complained of severe headache and convulsions on day 0, and findings on magnetic resonance images suggested CsA-induced encephalopathy. CsA was immediately stopped, and tacrolimus for prevention of graft-versus-host disease (GVHD) was started on day 2. Hematological engraftment was observed on day 14 without serious GVHD. Prompt diagnosis, replacement of immunosuppressive agents, and careful monitoring of serum drug concentrations are thought to have contributed to the patient's good clinical course, since CsA-induced encephalopathy tends to be recurrent but to improve completely without any sequelae. Bone Marrow Transplantation (2001) 28, 713–715.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schwartz RB, Bravo SM, Klufas RA et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy Am J Radiol 1995 165: 627–631
Fiorani L, Bandini G, D'Alessandro R et al. Cyclosporin A neurotoxicity after allogeneic bone marrow transplantation Bone Marrow Transplant 1994 14: 175–176
Kochi S, Takanaga H, Matsuo H et al. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells Eur J Pharmacol 1999 372: 287–295
De Groen PC, Aksamit AJ, Rakcla J et al. Central nervous system toxicity after liver transplantation N Engl J Med 1987 317: 861–866
Thompson CB, June CH, Sullivan KM et al. Association between cyclosporin neurotoxicity and hypomagnesaemia Lancet 1984 2: 1116–1120
Teshima T, Miyoshi T, Ono M . Cyclosporine-related encephalopathy following allogeneic bone marrow transplantation Int J Hematol 1996 63: 161–164
Reece DE, Frei-Lahr DA, Shepherd JD et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine Bone Marrow Transplant 1991 8: 393–401
Gijtenbeek JM, van den Bent MJ, Vecht CJ . Cyclosporine neurotoxicity: a review J Neurol 1999 246: 339–346
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahata, M., Hashino, S., Izumiyama, K. et al. Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. Bone Marrow Transplant 28, 713–715 (2001). https://doi.org/10.1038/sj.bmt.1703221
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703221
Keywords
This article is cited by
-
Challenges in managing graft-versus-host disease in developing countries: a perspective
Bone Marrow Transplantation (2019)
-
Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis
Bone Marrow Transplantation (2017)
-
Entzündliche Erkrankungen des ZNS sowie immunmodulatorische Therapie und ihr Einfluss auf primäre Kopfschmerzen
Der Schmerz (2007)